NYSE | TSX: ACB

 Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) ( TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the ” Meeting “) held on Thursday, November 12, 2020 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 48,828,603, representing 40.34% of Aurora’s issued and outstanding common shares.


All of the matters put forward before shareholders for consideration and approval, as set out in the Company’s Management Information Circular dated September 28, 2020 , were approved by the requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below:

Nominee

Votes For

Votes Withheld

Miguel Martin

9,114,731
(90.05%)

1,007,078

(9.95%)

Michael Singer

8,327,088

(82.27%)

1,794,722

(17.73%)

Ron Funk

8,920,391

(88.13%)

1,201,419

(11.87%)

Norma Beauchamp

8,901,696

(87.95%)

1,220,113

(12.05%)

Margaret Shan Atkins

8,965,142
(88.57%)

1,156,667

(11.43%)

Adam Szweras

8,642,769
(85.39%)

1,479,040
(14.61%)

Michael Detlefsen

9,009,767

(89.01%)

1,112,043

(10.99%)

Lance Friedmann

8,894,788

(87.88%)

1,227,022

(12.12%)

Shareholders also approved the following matters:

  • appointment of KPMG LLP as auditors of the Company for the ensuing year;
  • renewal of the Company’s 10% “rolling” stock option plan;
  • adoption of the Company’s fixed performance share unit plan;
  • an amendment to each of the Company’s fixed restricted share unit plan and fixed deferred share unit plan to increase the number of common shares issuable under each plan; and
  • a non-binding advisory resolution on the Company’s approach to executive compensation

The Company has filed a report of voting results on all resolutions voted on at the Meeting on www.sedar.com

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .

Aurora’s Common Shares trade on the TSX and NYSE under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/aurora-announces-results-of-2020-annual-general-and-special-meeting-301173281.html

SOURCE Aurora Cannabis Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2020/16/c5177.html

News Provided by Canada Newswire via QuoteMedia

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less